These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 21189151

  • 1. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA.
    Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W, Goryachkina L, Jacques L, Frith L.
    Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 6. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M, Delea TE, Stanford RH.
    Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
    Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
    [Abstract] [Full Text] [Related]

  • 8. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
    Hagiwara M, Delea TE, Stanford RH, Stempel DA.
    Allergy Asthma Proc; 2010 Sep; 31(3):203-10. PubMed ID: 20534183
    [Abstract] [Full Text] [Related]

  • 9. Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma.
    Renzi PM, Howard LA, Ortega HG, Ahmad FF, Chapman KR.
    Respir Med; 2010 Apr; 104(4):510-7. PubMed ID: 19944581
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 11. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Apr; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
    Chang Gung Med J; 2011 Apr; 34(4):382-94. PubMed ID: 21880193
    [Abstract] [Full Text] [Related]

  • 14. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Mar; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 17. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 29; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 20. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
    Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.